Elva Serna

546 total citations
17 papers, 466 citations indexed

About

Elva Serna is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Organic Chemistry. According to data from OpenAlex, Elva Serna has authored 17 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 15 papers in Public Health, Environmental and Occupational Health and 11 papers in Organic Chemistry. Recurrent topics in Elva Serna's work include Trypanosoma species research and implications (16 papers), Research on Leishmaniasis Studies (15 papers) and Synthesis and Biological Evaluation (11 papers). Elva Serna is often cited by papers focused on Trypanosoma species research and implications (16 papers), Research on Leishmaniasis Studies (15 papers) and Synthesis and Biological Evaluation (11 papers). Elva Serna collaborates with scholars based in Paraguay, Uruguay and France. Elva Serna's co-authors include Gloria Yaluff, Ninfa Vera de Bilbao, Susana Torres, Hugo Cerecetto, Mercedes González, Antonieta Rojas de Árias, Héctor Nakayama, Javier Varela, Guzmán Álvarez and Marı́a Elena Ferreira and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Molecules.

In The Last Decade

Elva Serna

17 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elva Serna Paraguay 13 264 243 207 110 53 17 466
Ninfa Vera de Bilbao Paraguay 12 257 1.0× 218 0.9× 222 1.1× 127 1.2× 38 0.7× 28 491
Susana Torres Paraguay 15 281 1.1× 251 1.0× 253 1.2× 147 1.3× 71 1.3× 30 621
Caio Haddad Franco Brazil 14 226 0.9× 285 1.2× 262 1.3× 119 1.1× 19 0.4× 26 523
Juliana Tonini Mesquita Brazil 16 151 0.6× 195 0.8× 249 1.2× 142 1.3× 26 0.5× 20 493
Valérie Landry France 13 289 1.1× 194 0.8× 163 0.8× 211 1.9× 119 2.2× 22 622
Richard M. Beteck South Africa 13 319 1.2× 98 0.4× 132 0.6× 252 2.3× 37 0.7× 49 616
Edwin O. Nuzum United States 9 271 1.0× 130 0.5× 327 1.6× 200 1.8× 28 0.5× 10 755
Lucie Paloque France 14 287 1.1× 114 0.5× 341 1.6× 118 1.1× 12 0.2× 35 638
Milene Höehr de Moraes Brazil 10 139 0.5× 208 0.9× 198 1.0× 90 0.8× 42 0.8× 22 413
Érika Izumi Brazil 8 91 0.3× 165 0.7× 154 0.7× 119 1.1× 40 0.8× 10 372

Countries citing papers authored by Elva Serna

Since Specialization
Citations

This map shows the geographic impact of Elva Serna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elva Serna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elva Serna more than expected).

Fields of papers citing papers by Elva Serna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elva Serna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elva Serna. The network helps show where Elva Serna may publish in the future.

Co-authorship network of co-authors of Elva Serna

This figure shows the co-authorship network connecting the top 25 collaborators of Elva Serna. A scholar is included among the top collaborators of Elva Serna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elva Serna. Elva Serna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bilbao, Ninfa Vera de, Marı́a Elena Ferreira, A. Paulina de la Mata, et al.. (2025). Exploring the Anti-Chagas Activity of Zanthoxylum chiloperone’s Seedlings Through Metabolomics and Protein–Ligand Docking. Plants. 14(6). 954–954. 1 indexed citations
2.
Aguilera, Elena, Leticia Pérez‐Díaz, Elva Serna, et al.. (2022). Preclinical Studies and Drug Combination of Low-Cost Molecules for Chagas Disease. Pharmaceuticals. 16(1). 20–20. 1 indexed citations
3.
Aguilera, Elena, Ileana Corvo, Paula Faral‐Tello, et al.. (2021). Preclinical Studies in Anti-Trypanosomatidae Drug Development. Pharmaceuticals. 14(7). 644–644. 2 indexed citations
4.
Aguilera, Elena, Ileana Corvo, Paula Faral‐Tello, et al.. (2019). A Nature-Inspired Design Yields a New Class of Steroids Against Trypanosomatids. Molecules. 24(20). 3800–3800. 13 indexed citations
5.
Aguilera, Elena, Javier Varela, Elva Serna, et al.. (2018). Looking for combination of benznidazole and Trypanosoma cruzi-triosephosphate isomerase inhibitors for Chagas disease treatment. Memórias do Instituto Oswaldo Cruz. 113(3). 153–160. 13 indexed citations
6.
Ferreira, Marı́a Elena, Antonieta Rojas de Árias, Gloria Yaluff, et al.. (2018). Helietta apiculata:a tropical weapon against Chagas disease. Natural Product Research. 33(22). 3308–3311. 2 indexed citations
7.
Álvarez, Guzmán, Javier Varela, Sandra Milena Leal Pinto, et al.. (2015). Development of bis-thiazoles as inhibitors of triosephosphate isomerase from Trypanosoma cruzi. Identification of new non-mutagenic agents that are active in vivo. European Journal of Medicinal Chemistry. 100. 246–256. 36 indexed citations
8.
Faral‐Tello, Paula, Gloria Yaluff, Elva Serna, et al.. (2015). New approach towards the synthesis of selenosemicarbazones, useful compounds for Chagas' disease. European Journal of Medicinal Chemistry. 109. 107–113. 16 indexed citations
9.
10.
Varela, Javier, Elva Serna, Susana Torres, et al.. (2014). In Vivo Anti-Trypanosoma cruzi Activity of Hydro-Ethanolic Extract and Isolated Active Principles from Aristeguietia glutinosa and Mechanism of Action Studies. Molecules. 19(6). 8488–8502. 19 indexed citations
11.
Álvarez, Guzmán, Javier Varela, Gustavo A. Echeverría, et al.. (2014). Optimization of Antitrypanosomatid Agents: Identification of Nonmutagenic Drug Candidates with in Vivo Activity. Journal of Medicinal Chemistry. 57(10). 3984–3999. 43 indexed citations
12.
Álvarez, Guzmán, Javier Varela, Marcelo Fernández, et al.. (2014). Identification of a New Amide-Containing Thiazole as a Drug Candidate for Treatment of Chagas' Disease. Antimicrobial Agents and Chemotherapy. 59(3). 1398–1404. 42 indexed citations
13.
Benítez, Diego, Mauricio Cabrera, Paola Hernández, et al.. (2011). 3-Trifluoromethylquinoxaline N,N′-Dioxides as Anti-Trypanosomatid Agents. Identification of Optimal Anti-T. cruzi Agents and Mechanism of Action Studies. Journal of Medicinal Chemistry. 54(10). 3624–3636. 51 indexed citations
14.
Ferreira, Marı́a Elena, Gerardo Cebrián‐Torrejón, Ninfa Vera de Bilbao, et al.. (2010). Zanthoxylum chiloperone leaves extract: First sustainable Chagas disease treatment. Journal of Ethnopharmacology. 133(3). 986–993. 37 indexed citations
15.
Boiani, Lucı́a, Alejandra Gerpe, Vicente J. Arán, et al.. (2008). In vitro and in vivo antitrypanosomatid activity of 5-nitroindazoles. European Journal of Medicinal Chemistry. 44(3). 1034–1040. 41 indexed citations
16.
Ferreira, Marı́a Elena, Héctor Nakayama, Antonieta Rojas de Árias, et al.. (2006). Effects of canthin-6-one alkaloids from Zanthoxylum chiloperone on Trypanosoma cruzi-infected mice. Journal of Ethnopharmacology. 109(2). 258–263. 57 indexed citations
17.
Boiani, Mariana, Lucı́a Boiani, Ana Denicola, et al.. (2006). 2H-Benzimidazole 1,3-Dioxide Derivatives:  A New Family of Water-Soluble Anti-Trypanosomatid Agents. Journal of Medicinal Chemistry. 49(11). 3215–3224. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026